These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 34867819)

  • 21. Regulation of Angiotensin-Converting Enzyme 2: A Potential Target to Prevent COVID-19?
    Hu Y; Liu L; Lu X
    Front Endocrinol (Lausanne); 2021; 12():725967. PubMed ID: 34745001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A potential therapeutic combination for treatment of COVID-19: Synergistic effect of DPP4 and RAAS suppression.
    Phyu Khin P; Cha SH; Jun HS; Lee JH
    Med Hypotheses; 2020 Nov; 144():110186. PubMed ID: 33254506
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dysregulation of ACE (Angiotensin-Converting Enzyme)-2 and Renin-Angiotensin Peptides in SARS-CoV-2 Mediated Mortality and End-Organ Injuries.
    Wang K; Gheblawi M; Nikhanj A; Munan M; MacIntyre E; O'Neil C; Poglitsch M; Colombo D; Del Nonno F; Kassiri Z; Sligl W; Oudit GY
    Hypertension; 2022 Feb; 79(2):365-378. PubMed ID: 34844421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiotensin-converting enzyme 2, coronavirus disease 2019, and abdominal aortic aneurysms.
    Xu B; Li G; Guo J; Ikezoe T; Kasirajan K; Zhao S; Dalman RL
    J Vasc Surg; 2021 Nov; 74(5):1740-1751. PubMed ID: 33600934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ACE2, the kidney and the emergence of COVID-19 two decades after ACE2 discovery.
    Lores E; Wysocki J; Batlle D
    Clin Sci (Lond); 2020 Nov; 134(21):2791-2805. PubMed ID: 33135725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ACE/ACE2 balance might be instrumental to explain the certain comorbidities leading to severe COVID-19 cases.
    Bank S; De SK; Bankura B; Maiti S; Das M; A Khan G
    Biosci Rep; 2021 Feb; 41(2):. PubMed ID: 33442728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene Networks of Hyperglycemia, Diabetic Complications, and Human Proteins Targeted by SARS-CoV-2: What Is the Molecular Basis for Comorbidity?
    Saik OV; Klimontov VV
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential detrimental role of soluble ACE2 in severe COVID-19 comorbid patients.
    Rahman MM; Hasan M; Ahmed A
    Rev Med Virol; 2021 Sep; 31(5):1-12. PubMed ID: 33426683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Downregulation of Membrane-bound Angiotensin Converting Enzyme 2 (ACE2) Receptor has a Pivotal Role in COVID-19 Immunopathology.
    Vieira C; Nery L; Martins L; Jabour L; Dias R; Simões E Silva AC
    Curr Drug Targets; 2021; 22(3):254-281. PubMed ID: 33081670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SARS-CoV-2 Infections, Impaired Tissue, and Metabolic Health: Pathophysiology and Potential Therapeutics.
    Singh SP; Bhatnagar A; Singh SK; Patra SK; Kanwar N; Kanwal A; Amar S; Manna R
    Mini Rev Med Chem; 2022; 22(16):2102-2123. PubMed ID: 35105287
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Issues of Cardiovascular Risk Management in People With Diabetes in the COVID-19 Era.
    Ceriello A; Standl E; Catrinoiu D; Itzhak B; Lalic NM; Rahelic D; Schnell O; Škrha J; Valensi P;
    Diabetes Care; 2020 Jul; 43(7):1427-1432. PubMed ID: 32409501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ACE2 function in the pancreatic islet: Implications for relationship between SARS-CoV-2 and diabetes.
    Memon B; Abdelalim EM
    Acta Physiol (Oxf); 2021 Dec; 233(4):e13733. PubMed ID: 34561952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An Assessment on Impact of COVID-19 Infection in a Gender Specific Manner.
    Agrawal H; Das N; Nathani S; Saha S; Saini S; Kakar SS; Roy P
    Stem Cell Rev Rep; 2021 Feb; 17(1):94-112. PubMed ID: 33029768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection.
    Verdecchia P; Cavallini C; Spanevello A; Angeli F
    Eur J Intern Med; 2020 Jun; 76():14-20. PubMed ID: 32336612
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcomes in Patients with COVID-19 Infection Taking ACEI/ARB.
    Rico-Mesa JS; White A; Anderson AS
    Curr Cardiol Rep; 2020 Apr; 22(5):31. PubMed ID: 32291526
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of plasma angiotensin II and angiotensin-converting enzyme 2 levels on prognosis and mortality in hypertensive patients with COVID-19.
    Biberoğlu S; İpekci A; İkizceli İ; Çakmak F; Akdeniz YS; Kanbakan A; Konukoğlu D; Bolayırlı İM; Börekçi Ş; Ürkmez S; Özkan S
    Biomark Med; 2021 Dec; 15(17):1581-1588. PubMed ID: 34704822
    [No Abstract]   [Full Text] [Related]  

  • 37. Exploring the Mystery of Angiotensin-Converting Enzyme II (ACE2) in the Battle against SARS-CoV-2.
    Sharma D; Sharma J; Singh A
    J Renin Angiotensin Aldosterone Syst; 2021; 2021():9939929. PubMed ID: 34285711
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cross-Talk Between Key Players in Patients with COVID-19 and Ischemic Stroke: A Review on Neurobiological Insight of the Pandemic.
    Kaushik P; Kaushik M; Parveen S; Tabassum H; Parvez S
    Mol Neurobiol; 2020 Dec; 57(12):4921-4928. PubMed ID: 32813238
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The COVID-19-diabetes mellitus molecular tetrahedron.
    Mahmudpour M; Vahdat K; Keshavarz M; Nabipour I
    Mol Biol Rep; 2022 May; 49(5):4013-4024. PubMed ID: 35067816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiotensin-Converting Enzyme 2 (ACE2) in the Pathogenesis of ARDS in COVID-19.
    Kuba K; Yamaguchi T; Penninger JM
    Front Immunol; 2021; 12():732690. PubMed ID: 35003058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.